Summary
Mania is a rare complication of prescribed drug use in elderly persons. The drugs most likely to produce mania include corticosteroids and dopamine agonists. It is uncertain if antidepressants cause mania or only increase the propensity for latent bipolar mania to be expressed.
Drug-induced mania may promote poor judgment, risk-taking behaviours and medical noncompliance. The majority of episodes of drug-induced mania are short-lived and respond to discontinuation of the drug. Antipsychotic agents may hasten resolution of this psychiatric syndrome. Lithium may prevent corticosteroid-induced mania, but the role of lithium in the treatment of other drug-induced manic episodes has not been studied adequately.
Similar content being viewed by others
References
Abramowicz M (Ed.). Drugs that cause psychiatric symptoms. Medical Letter on Drugs and Therapeutics 31: 113–118, 1989
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd ed., Revised, APA Press, Washington, DC, 1987
Arana GW, Pearlman C, Shader RI. Alprazolam-induced mania: two clinical cases. American Journal of Psychiatry 142: 368–369, 1985
Beresin EV. Delirium in the elderly. Journal of Geriatric Psychiatry and Neurology 1: 127–143, 1988
Boston Collaborative Drug Surveillance Program. Acute adverse reactibns to prednisone in relation to dosage. Clinical Pharmacology and Therapeutics 13: 694–698, 1972
Broadhead J, Jacoby R. Mania in old age: a first prospective study. International Journal of Geriatric Psychiatry 5: 215–222, 1990
Cade R, Spooner G, Shlein E, Pickering M, de Quesada A. Comparison of azathioprine, prednisone and heparin alone or combined in treating lupus nephritis. Nephron 10: 37–56, 1973
Calne DB, Stern GM, Laurence DR, Sharkey J, Armitage P. L-dopa in postencephalitic parkinsonism. Lancet 1: 744–747, 1969
Casey DE. Clozapine: neuroleptic-induced EPS and tardive dyskinesia. Psychopharmacology 99: S47–S53, 1989
Celesia GG, Barr AN. Psychosis and other psychiatric manifestations of levodopa therapy. Archives of Neurology 23: 193–200, 1970
Chouinard G, Steiner W. A case of mania induced by high dose fluoxetine treatment. American Journal of Psychiatry 143: 686, 1986
Delerue O, Muller JP, Destee A, Warot P. Mania-like episodes associated with ranitidine. American Journal of Psychiatry 145: 271, 1988
Dorevitch A. Mania associated with clonazepam. Drug Intelligence and Clinical Pharmacy 25: 938–939, 1991
Eagles JM, Whalley LJ. Ageing and affective disorders: the age at first onset of affective disorders in Scotland, 1966-1987. British Journal of Psychiatry 147: 180–187, 1985
Factor SA, Brown D. Clozapine prevents recurrence of psychosis in Parkinson’s disease. Movement Disorders 7: 125–131, 1992
Falk WE, Mahnke MW, Poskanzer DC. Lithium prophylaxis of corticotropin-induced psychosis. Journal of the American Medical Association 241: 1011–1012, 1979
Feder R. Fluoxetine-induced mania. Journal of Clinical Psychiatry 51: 524–525, 1990
Fichtner CG, Brown BG. Bupropion-associated mania in a patient with HIV infection. Journal of Clinical Psychopharmacology 12: 366–367, 1992
Friedman JH, Lannon MC. Clozapine in the treatment of psychosis in Parkinson’s disease. Neurology 39: 1219–1221, 1989
Glasser M, Rabins P. Mania in the elderly. Age and Ageing 13: 210–213, 1984
Godwin-Austin RB, Tomlinson EB, Frears CC, Kok HWL. Effects of l-dopa in Parkinson’s disease. Lancet 2: 165–168, 1969
Goodwin FK, Jamison KR. Manic-depressive illness, Oxford University Press, New York, 1990
Hall RCW, Popkin MK, Stickney SK, Gardner ER. Presentation of the steroid psychoses. Journal of Nervous and Mental Disease 167: 229–236, 1979
Harsch HH, Miller M, Young LD. Induction of mania by l-dopa in a nonbipolar patient. Journal of Clinical Psychopharmacology 5: 338–339, 1985
Hubain PP, Sobolski J, Mendlewicz J. Cimetidine-induced mania. Neuropsychobiology 8: 223–224, 1982
Jabeen S, Fisher CJ. Trazodone-induced transient hypomanic symptoms and their management. British Journal of Psychiatry 158: 275–278, 1991
Josephson AM, MacKenzie TB. Thyroid-induced mania in hypothyroid patients. British Journal of Psychiatry 137: 222–228, 1980
Jouvent R, Abensour P, Bonnet AM, Widlocher D, Agid Y, et al. Antiparkinsonian and antidepressant effects of high doses of bromocriptine. Journal of Affective Disorders 5: 141–145, 1983
Kahn N, Freeman A, Juncos JL, Manning D, Watts RL. Clozapine is beneficial for psychosis in Parkinson’s disease. Neurology 41: 1699–1700, 1989
Kaufmann MW, Cassadonte PE, Peselow ED. Steroid psychosis. New York State Journal of Medicine 81: 1795–1797, 1981
Kershner P, Wang-Cheng R. Psychiatric side effects of steroid therapy. Psychosomatics 30: 135–139, 1989
Knobler HY, Itzchaky S, Emanuel D, Mester R, Maizel S. Trazodone-induced mania. British Journal of Psychiatry 149: 787–789, 1986
Ko GN, Leckman JF, Henninger GR. Induction of rapid mood cycling during L-dopa treatment in a bipolar patient. American Journal of Psychiatry 138: 1624–1625, 1981
Kupfer DJ, Carpenter LL, Frank E. Possible role of antidepressants in precipitating mania and hypomania in recurrent depression. American Journal of Psychiatry 145: 804–808, 1988
Kurlan R, Dimitsopulos T. Selegiline and manic behaviour in Parkinson’s disease. Archives of Neurology 49: 1231, 1992
Krauthammer C, Klerman GL. Secondary mania: manic syndromes associated with antecedent physical illness or drugs. Archives of General Psychiatry 35: 1333–1339, 1978
Lewis DA, Smith RE. Steroid-induced psychiatric syndromes: a report of 14 cases and a review of the literature. Journal of Affective Disorders 5: 319–332, 1983
Lin JT, Ziegler DK. Psychiatric symptoms with initiation of carbidopa-levodopa treatment. Neurology 26: 699–700, 1976
Ling MHM, Perry PJ, Tsuang MT. Side effects of corticosteroid therapy. Archives of General Psychiatry 38: 471–477, 1981
Lipowski ZJ. Delirium: acute confusional states, Oxford University Press, New York, 1990
Muenter MD. Double-blind, placebo-controlled study of levodopa therapy in Parkinson’s disease. Neurology 20: 6–13, 1970
Murphy DL, Brodie HKH, Goodwin FK, Bunney WE. Regular induction of hypomania by l-dopa in bipolar’ manic-depressive patients. Nature 229: 135–136, 1971
O’Brien CP, DiGiacon JN, Fahn S, Schwarz GA. Mental Effects of high-dosage levodopa. Archives of General Psychiatry 24: 61–64, 1971
Patten SB, Brager N, Sanders S. Manic symptoms associated with the use of captopril. Canadian Journal of Psychiatry 36: 314–315, 1991
Patterson JF. Mania associated with intravenous ranitidine therapy. Southern Medical Journal 80: 1467, 1987
Perry PJ, Tsuang MT, Hwang MH. Prednisolone psychosis: clinical observations. Drug Intelligence and Clinical Pharmacy 18: 603–609, 1984
Pfeiffer RF, Kang J, Graber B, Hofman R, Wilson J. Clozapine for psychosis in Parkinson’s disease. Movement Disorders 5: 239–242, 1990
Pope HG, Katz DL. Affective and psychotic symptoms associated with anabolic steroid use. American Journal of Psychiatry 145: 487–490, 1988
Presthus J, Holmsen R. Appraisal of long-term levodopa treatment of parkinsonism with special reference to therapy limiting factors. Acta Neurologica Scandinavica 50: 774–790, 1974
Przedborski S, Liard A, Hildebrand J. Induction of mania by apomorphine in a depressed parkinsonian patient. Movement Disorders 7: 285–287
Rego MD, Giller EL. Mania secondary to amantadine treatment of neuroleptic-induced hyperprolactinemia. Journal of Clinical Psychiatry 50: 143–144, 1989
Rigby J, Harvey M, Davies DR. Mania precipitated by benzodiazepine withdrawal. Acta Psychiatrica Scandinavica 79: 406–407, 1989
Ryback RS, Schwab RS. Manic response to levodopa therapy: report of a case. New England Journal of Medicine 285: 788–789, 1971
Sergent JS, Lockshin MD, Klemper MS, Lipsky BA. Central nervous system disease in systemic lupus erythematosus. American Journal of Medicine 58: 644–654, 1975
Shulman K, Post F. Bipolar affective disorder in old age. British Journal of Psychiatry 136: 26–32, 1980
Spicer CC, Hare EH, Slater E. Neurotic and psychotic forms of depressive illness: evidence from age incidence in a national sample. British Journal of Psychiatry 123: 535–541, 1973
Stasiek C, Zetin M. Organic manic disorders. Psychosomatics 26: 394–399, 1985
Stone K. Mania in the elderly. British Journal of Psychiatry 155: 220–224, 1989
Strahan A, Rosenthal J, Kaswan M, Winston A. Three case reports of acute paroxysmal excitement associated with alprazolam treatment. American Journal of Psychiatry 142: 859–861, 1985
Sultzer DL, Cummings JL. Drug-induced mania - causative agents, clinical characteristics and management: a retrospective analysis of the literature. Medical Toxicology and Adverse Drug Experience 4: 127–143, 1989
Titus JP. Cimetidine-induced mania in depressed patients. Journal of Clinical Psychiatry 44: 267–268, 1983
Turner TH, Cookson JC, Wass JAH, Drury PL, Price PA, et al. Psychotic reactions during treatment of pituitary tumours with dopamine agonists. British Medical Journal 289: 1101–1103, 1984
Young RC. Geriatric mania. Clinics in Geriatric Medicine 8: 387–399, 1992
van Scheyen JD, van Kammen DP. Clomipramine-induced mania in unipolar depression. Archives of General Psychiatry 36: 560–565, 1979
Van Woert MH. Ambani LM, Weintraub MI. Manic behavior and levodopa. New England Journal of Medicine 285: 1326–1327, 1971
Warren M, Bick PA. Two case reports of trazodone-induced mania. American Journal of Psychiatry 141: 1103–1104, 1984
Wehr TA, Goodwin FK. Can antidepressants cause mania and worsen the course of affective illness? American Journal of Psychiatry 144: 1403–1411, 1987
Weilburg JB, Sachs G, Falk WE. Triazolam-induced brief episodes of secondary mania in a depressed patient. Journal of Clinical Psychiatry 48: 492–493, 1987
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ganzini, L., Millar, S.B. & Walsh, J.R. Drug-Induced Mania in the Elderly. Drugs & Aging 3, 428–435 (1993). https://doi.org/10.2165/00002512-199303050-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002512-199303050-00004